Back to top

genomics: Archive

Zacks Equity Research

QURE Stock Skyrockets on Meeting Goals in Huntington's Disease Study

uniQure N.V. shares surge nearly 248% after its gene therapy candidate, AMT-130, met key goals in a pivotal Huntington's disease study.

CRMDPositive Net Change QUREPositive Net Change KNSAPositive Net Change PHARPositive Net Change

Ekta Bagri

3 Promising Genomics & Synthetic Biology Stocks in Spotlight in 2025

GeneDx, Twist Bioscience and Wave Life Sciences are emerging as key players in the fast-growing genomics and synthetic biology space.

ILMNPositive Net Change BEAMPositive Net Change WVEPositive Net Change CRSPNegative Net Change TWSTPositive Net Change WGSPositive Net Change